Although regulatory T cells protect people from autoimmunity, two recent papers in Immunity (Malchow et al., 2016; Kieback et al., 2016) demonstrate that these cells are also a crisis averted. Without the proper education in the thymus, these cells will turn on their host and cause autoimmunity.
CD4
+ T cells respond to infections and cancer by using T cell receptors (TCRs) to recognize foreign peptides bound to major histocompatibility complex class II (MHCII) molecules displayed on antigenpresenting cells. Each nascent T cell in the thymus generates a unique TCR by gene segment recombination and then just as Goldilocks chose her porridge, these cells are selected according to TCR affinity for self-peptide:MHCII ligands. Thymocytes with TCRs that have no affinity for self-peptide:MHCII ligands die due to a lack of TCR signaling (neglect). In contrast, thymocytes with TCRs that have moderate affinity for a self-peptide:MHCII ligand receive weak TCR signals that cause the cells to become conventional CD4 + T cells lacking the transcription factor Foxp3. These cells seed the secondary lymphoid organs, forming a vast and diverse repertoire. During an infection, a few cells from this repertoire will by chance express TCRs that recognize MHCII-bound microbial peptides with high affinity. These cells will become activated, proliferate, and differentiate into microbekilling effector cells. Finally, those thymocytes with TCRs with the highest affinity for self-peptide:MHCII ligands are deleted or become Foxp3 + regulatory T cells that do not produce tissue-damaging cytokines and instead suppress T cells that might. We have recently shown that the amount of self-peptide:MHCII presentation in the thymus determines the size and regulatory T cell composition of selfpeptide:MHCII-specific CD4 + T cell repertoires (Malhotra et al., 2016) . For thymically-induced tolerance (central tolerance) to be effective, all MHCIIbound self-peptides that are displayed in secondary lymphoid organs (and thus could activate conventional CD4 + T cells) must also be displayed by thymic antigen-presenting cells. This occurs in large part because many proteins are taken up or expressed by antigen-presenting cells in both locations. However, some proteins have highly tissue-specific functions and therefore restricted patterns of expression. Autoimmune regulator (Aire) drives promiscuous expression of many of these proteins in medullary thymic epithelial cells. Thymic dendritic cells efferocytose epithelial cells and present peptides from the tissue-restricted proteins on MHCII molecules, allowing for tolerance of T cells with high-affinity TCRs for these ligands. The organ-specific autoimmunity that develops in Airedeficient individuals highlights the importance of this self-tolerance mechanism (Anderson et al., 2002; Mathis and Benoist, 2009 ).
Several fundamental questions emerge from the observation that the absence of tissue-restricted protein expression in the thymuses of Aire-deficient individuals leads to organ-specific autoimmunity. Are self-reactive thymocytes that encounter MHCII-bound peptides from peripheral tissue-restricted proteins primarily deleted or are they channeled into the regulatory T cell lineage? How does the strength of self-peptide:MHCII recognition influence the balance between the regulatory and conventional T cell fates? Kieback et al. (2016) and Malchow et al. (2016) tackled these challenging questions by analyzing the repertoires of CD4 + T cells specific for MHCII-bound peptides from tissue-restricted proteins. These complementary studies demonstrate that thymocytes with strong recognition of self-peptide:MHCII ligands had a tendency to become regulatory T cells. Thymocytes with weaker selfpeptide:MHCII recognition became conventional CD4 + T cells. Importantly, when the relevant self-protein was ablated from the thymus, many thymocytes that expressed TCRs that normally promoted regulatory T cell induction were instead shunted into the conventional T cell pool and caused pathology (Figure 1 ). Consistent with a theme emerging from other studies, clonal deletion played a surprisingly small role in tolerance to tissue-restricted proteins (Legoux et al., 2015; Malhotra et al., 2016; Yu et al., 2015) .
Both studies assessed how self-peptide:MHCII encounter in the thymus shapes the T cell repertoire by manipulating expression of self-peptides. Kieback (Hsieh et al., 2004) . Conversely, regulatory T cells that were engineered to express MOGp:MHCIIspecific TCRs from other regulatory T cells suppressed disease better than regulatory T cells engineered to express MOGp:MHCII-specific TCRs from conventional T cells. Thus, thymocytes with strong recognition of self-peptide:MHCII become regulatory T cells, thereby preventing autoimmunity.
Kieback and colleagues hypothesized that TCR signaling in response to MOGp:MHCII encounter instructs thymic regulatory T differentiation. Indeed, MOG-expressing mice contained more MOGp:MHCII-specific thymic regulatory T cells than MOG-deficient mice. MOGp:MHCII-specific regulatory T cell generation, however, was not completely eliminated in mice lacking MOG. Thus, some MOGp:MHCII-reactive regulatory T cells must be selected on MHCII-bound peptides from proteins other than MOG. These proteins might contain peptides that when bound to MHCII display similar outward pointing amino acids as MOGp, and thus look like MOGp:MHCII complexes to some TCRs (Birnbaum et al., 2014; Nelson et al., 2015 T cells, not too far from the 30% that we recently reported (Malhotra et al., 2016) . It is prudent, however, not to underestimate clonal deletion as nearly 700,000 thymocytes are clonally deleted per hour in the murine thymus (Stritesky et al., 2013) , and these studies could not evaluate thymocytes that were deleted after recognition of self-peptide:MHCII ligands with similar TCR contact residues that were derived from non-Aire-regulated proteins. These studies suggest that a key function of thymic self-peptide:MHCII encounter is to channel highly self-reactive thymocytes to the regulatory T cell lineage, thereby protecting us from autoimmunity. However, the molecular mechanisms that translate these high-affinity interactions into thymocyte reprograming remain to be elucidated. Furthermore, an alluring possibility that emerges from these studies is that by virtue of this potent self-reactivity, expression of regulatory T cell-derived TCRs in conventional T cells might yield an alternative therapeutic approach for combating cancers for which self-tolerance limits clearance. Thus, while regulatory T cell development Self-peptides are displayed by major histocompatibility complex molecules (MHC) on the surface of thymic antigen-presenting cells. Thymocyte T cell receptors (TCRs) might have high affinity for one selfpeptide:MHCII complex (self-peptide 1:MHCII) and lower affinity for another (self-peptide 2:MHCII). Developing T cells that undergo high-affinity interactions with self-peptide 1:MHCII (top, left) are channeled to the regulatory T cell (Treg) lineage or deleted (top, center). The decision between clonal deletion and Treg cell induction likely depends on the frequency of self-peptide 1:MHCII ligand encounter in the thymus. Repeated high-affinity interactions might promote clonal deletion, whereas fewer such encounters might instead induce Treg cell generation. Lower-affinity interactions with self-peptide 2:MHCII would allow entry into the conventional T cell (Tconv) pool. Treg cell induction following thymic encounter of self-peptide 1:MHCII prevents autoimmune disease in the periphery (top, right). The absence of selfpeptide 1:MHCII from the thymus (as might occur in Aire À/À mice due to a lack of promiscuous expression of tissue-restricted proteins) allows developing T cells to undergo lower-affinity interactions with other ligands such as self-peptide 2:MHCII (bottom, left), and to enter the Tconv cell pool (bottom, center). These highly self-reactive cells then move into the periphery where they can become activated, proliferate, and cause inflammation in response to self-peptide 1:MHCII encounter (bottom, right).
in the thymus prevents autoimmunity, it also helpfully tags our best source of highly self-reactive TCRs, which we might one day tap into to avert an entirely different kind of crisis.
